434 related articles for article (PubMed ID: 28888902)
1. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.
Deshmukh V; Hu H; Barroga C; Bossard C; Kc S; Dellamary L; Stewart J; Chiu K; Ibanez M; Pedraza M; Seo T; Do L; Cho S; Cahiwat J; Tam B; Tambiah JRS; Hood J; Lane NE; Yazici Y
Osteoarthritis Cartilage; 2018 Jan; 26(1):18-27. PubMed ID: 28888902
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.
Deshmukh V; O'Green AL; Bossard C; Seo T; Lamangan L; Ibanez M; Ghias A; Lai C; Do L; Cho S; Cahiwat J; Chiu K; Pedraza M; Anderson S; Harris R; Dellamary L; Kc S; Barroga C; Melchior B; Tam B; Kennedy S; Tambiah J; Hood J; Yazici Y
Osteoarthritis Cartilage; 2019 Sep; 27(9):1347-1360. PubMed ID: 31132406
[TBL] [Abstract][Full Text] [Related]
3. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
Yazici Y; McAlindon TE; Fleischmann R; Gibofsky A; Lane NE; Kivitz AJ; Skrepnik N; Armas E; Swearingen CJ; DiFrancesco A; Tambiah JRS; Hood J; Hochberg MC
Osteoarthritis Cartilage; 2017 Oct; 25(10):1598-1606. PubMed ID: 28711582
[TBL] [Abstract][Full Text] [Related]
4. Intra-articular injection of a novel Wnt pathway inhibitor, SM04690, upregulates Wnt16 expression and reduces disease progression in temporomandibular joint osteoarthritis.
Hua B; Qiu J; Ye X; Liu X
Bone; 2022 May; 158():116372. PubMed ID: 35218985
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling: a promising target for osteoarthritis therapy.
Wang Y; Fan X; Xing L; Tian F
Cell Commun Signal; 2019 Aug; 17(1):97. PubMed ID: 31420042
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of the Wnt pathway, lorecivivint (SM04690), as a potential disease-modifying agent for the treatment of degenerative disc disease.
Deshmukh V; Ibanez M; Hu H; Cahiwat J; Wei Y; Stewart J; Hood J; Yazici Y
Spine J; 2020 Sep; 20(9):1492-1502. PubMed ID: 32413487
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-(1-34) ameliorated knee osteoarthritis in rats via autophagy.
Chen CH; Ho ML; Chang LH; Kang L; Lin YS; Lin SY; Wu SC; Chang JK
J Appl Physiol (1985); 2018 May; 124(5):1177-1185. PubMed ID: 29357491
[TBL] [Abstract][Full Text] [Related]
8. [The role of Wnt signaling pathway in osteoarthritis via the dual-targeted regulation of cartilage and subchondral bone].
Lian Q; Chi B; Zhang L; Tian F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Jun; 34(6):797-803. PubMed ID: 32538575
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin Ameliorates Osteoarthritis by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Zhong G; Liang R; Yao J; Li J; Jiang T; Liu J; Le Y; Shen C; Long H; Lu H; Ma S; Luo J; Miao Z; Su W; Zheng L; Zhao J
Cell Physiol Biochem; 2018; 51(6):2575-2590. PubMed ID: 30562742
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of a carbohydrate analog for reducing arthritic inflammation and rebuilding cartilage.
Kim C; Jeon OH; Kim DH; Chae JJ; Shores L; Bernstein N; Bhattacharya R; Coburn JM; Yarema KJ; Elisseeff JH
Biomaterials; 2016 Mar; 83():93-101. PubMed ID: 26773662
[TBL] [Abstract][Full Text] [Related]
11. Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug.
Sabha M; Siaton BC; Hochberg MC
Expert Opin Investig Drugs; 2020 Dec; 29(12):1339-1346. PubMed ID: 33096010
[No Abstract] [Full Text] [Related]
12. GABARAP promotes bone marrow mesenchymal stem cells-based the osteoarthritis cartilage regeneration through the inhibition of PI3K/AKT/mTOR signaling pathway.
Wu Z; Lu H; Yao J; Zhang X; Huang Y; Ma S; Zou K; Wei Y; Yang Z; Li J; Zhao J
J Cell Physiol; 2019 Nov; 234(11):21014-21026. PubMed ID: 31020644
[TBL] [Abstract][Full Text] [Related]
13. Development and functional evaluation of a hyaluronic acid coated nano-formulation with kaempferol as a novel intra-articular agent for Knee Osteoarthritis treatment.
Lee CY; Chang YC; Yang KC; Lin YF; Wu ATH; Tseng CL
Biomed Pharmacother; 2024 Jun; 175():116717. PubMed ID: 38749179
[TBL] [Abstract][Full Text] [Related]
14. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees.
Weng LH; Wang CJ; Ko JY; Sun YC; Wang FS
Arthritis Rheum; 2010 May; 62(5):1393-402. PubMed ID: 20131282
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Wnt/β-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis.
Lietman C; Wu B; Lechner S; Shinar A; Sehgal M; Rossomacha E; Datta P; Sharma A; Gandhi R; Kapoor M; Young PP
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415892
[TBL] [Abstract][Full Text] [Related]
16. Jiawei Yanghe decoction ameliorates cartilage degradation in vitro and vivo via Wnt/β-catenin signaling pathway.
Xia H; Cao D; Yang F; Yang W; Li W; Liu P; Wang S; Yang F
Biomed Pharmacother; 2020 Feb; 122():109708. PubMed ID: 31918279
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the Wnt Signaling Pathway and Synovial Stem Cell Dysfunction in Osteoarthritis Development.
Huang J; Chen C; Liang C; Luo P; Xia G; Zhang L; Wang X; Wen Z; Cao X; Wu S
Stem Cells Dev; 2020 Apr; 29(7):401-413. PubMed ID: 31964233
[TBL] [Abstract][Full Text] [Related]
18. Targeting β-catenin dependent Wnt signaling via peptidomimetic inhibitors in murine chondrocytes and OA cartilage.
Held A; Glas A; Dietrich L; Bollmann M; Brandstädter K; Grossmann TN; Lohmann CH; Pap T; Bertrand J
Osteoarthritis Cartilage; 2018 Jun; 26(6):818-823. PubMed ID: 29559252
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular injection of the selective cyclooxygenase-2 inhibitor meloxicam (Mobic) reduces experimental osteoarthritis and nociception in rats.
Wen ZH; Tang CC; Chang YC; Huang SY; Chen CH; Wu SC; Hsieh SP; Hsieh CS; Wang KY; Lin SY; Lee HL; Lee CH; Kuo HC; Chen WF; Jean YH
Osteoarthritis Cartilage; 2013 Dec; 21(12):1976-86. PubMed ID: 24084190
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor).
Nishida T; Kubota S; Kojima S; Kuboki T; Nakao K; Kushibiki T; Tabata Y; Takigawa M
J Bone Miner Res; 2004 Aug; 19(8):1308-19. PubMed ID: 15231019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
